Key facts
| Price (PPV) | 29,573 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | sélexipag |
| Class | Antithrombotic agents |
| ATC code | B01AC27 |
| Manufacturer | MAPHAR |
| Presentation | Boite de 60 |
| Hospital price | 29,001 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l'hypertension artérielle pulmonaire (HTAP) chez les patients atteints d'une limitation fonctionnelle avancée (classe fonctionnelle III/IV de la NYHA) pour retarder la progression de la maladie.
Find an open pharmacy
On-call pharmacies near you
About Uptravi 1000 µg
Uptravi 1000 µg belongs to the antithrombotic agents therapeutic class. In Morocco, this drug is marketed by MAPHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Uptravi 1000 µg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Uptravi 1000 µg
Answers to common questions from Moroccan patients about this drug.